v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net increase in net assets from operations $ 85,516 $ 52,987
Adjustments to reconcile net increase in net assets from operations to net cash (used in) provided by operating activities:    
Purchases and originations of investments (524,681) (466,893)
Proceeds from sales and repayments of debt investments in portfolio companies 273,602 226,909
Proceeds from sales and return of capital of equity investments in portfolio companies 31,520 0
Payment of accreted original issue discounts 2,141 1,839
Payment of accrued payment-in-kind interest 510 23
Depreciation and amortization 5,211 4,193
Net pension benefit (50) (49)
Realized (gain) loss on investments before income tax (17,550) 22,431
Realized loss on extinguishment of debt 2,154 387
Realized loss on extinguishment of debt 2,156 387
Realized loss on disposal of fixed assets 2 9
Net unrealized depreciation on investments before income tax 23,901 11,854
Accretion of discounts on investments (7,333) (4,731)
Payment-in-kind interest (10,137) (8,804)
Share-based compensation expense 3,703 4,306
Deferred income taxes (1,753) 3,631
Changes in other assets and liabilities:    
Increase in dividend and interest receivable (6,402) (5,994)
(Increase) decrease in escrow receivables (75) 23
Increase in tax receivable (345) (332)
Increase in other receivables (575) (3,455)
Increase in other assets (154) (1,447)
(Decrease) increase in taxes payable (480) 969
Increase in other liabilities 6,910 3,614
Net cash (used in) provided by operating activities (134,365) (158,530)
Cash flows from investing activities    
Acquisition of fixed assets (237) (1,270)
Net cash used in investing activities (237) (1,270)
Cash flows from financing activities    
Proceeds from common stock offering 132,661 110,951
Borrowings under Credit Facilities 523,000 274,000
Repayments of Credit Facilities (552,000) (231,000)
Debt issuance costs paid (1,763) (1,553)
Proceeds from issuance of SBA Debentures 19,513 21,464
Proceeds from issuance of September 2030 Notes 344,208 0
Proceeds from issuance of 2029 Convertible Notes 0 223,100
Dividends to shareholders (108,683) (91,560)
Common stock withheld for payroll taxes upon vesting of restricted stock (1,121) (1,862)
Net cash provided by financing activities 133,940 163,540
Net (decrease) increase in cash, cash equivalents and restricted cash (662) 3,740
Cash and cash equivalents at beginning of period 44,871 32,273
Cash, cash equivalents and restricted cash at end of period 44,209 36,013
Supplemental cash flow disclosures:    
Cash paid for income taxes 10,046 184
Cash paid for interest 41,053 32,494
Total cash, cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows    
Cash and cash equivalents 42,559 36,013
Restricted cash 1,650 0
Total cash, cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows 44,209 36,013
January 2026 Notes    
Cash flows from financing activities    
Redemption of notes 0 (140,000)
October 2026 Notes    
Cash flows from financing activities    
Redemption of notes (150,000) 0
August 2028 Notes    
Cash flows from financing activities    
Redemption of notes $ (71,875) $ 0